David Bonekamp
Overview
Explore the profile of David Bonekamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
3391
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Glemser P, Freitag M, Kovacs B, Netzer N, Dimitrakopoulou-Strauss A, Haberkorn U, et al.
EJNMMI Rep
. 2024 Nov;
8(1):37.
PMID: 39510993
Background: To investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in...
2.
Twilt J, Saha A, Bosma J, van Ginneken B, Bjartell A, Padhani A, et al.
Eur Urol
. 2024 Oct;
87(2):240-250.
PMID: 39438187
Background And Objective: Biparametric magnetic resonance imaging (bpMRI), excluding dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI), is a potential replacement for multiparametric MRI (mpMRI) in diagnosing clinically significant prostate cancer...
3.
Baumgartner K, Byczkowski M, Schmid T, Muschko M, Woessner P, Gerlach A, et al.
Eur Urol Open Sci
. 2024 Sep;
69:80-88.
PMID: 39329071
Background And Objective: Artificial intelligence (AI)-powered conversational agents are increasingly finding application in health care, as these can provide patient education at any time. However, their effectiveness in medical settings...
4.
Schrader A, Netzer N, Hielscher T, Gortz M, Zhang K, Schutz V, et al.
Eur Radiol
. 2024 Jul;
34(12):7909-7920.
PMID: 38955845
Objectives: Risk calculators (RCs) improve patient selection for prostate biopsy with clinical/demographic information, recently with prostate MRI using the prostate imaging reporting and data system (PI-RADS). Fully-automated deep learning (DL)...
5.
Saha A, Bosma J, Twilt J, van Ginneken B, Bjartell A, Padhani A, et al.
Lancet Oncol
. 2024 Jun;
25(7):879-887.
PMID: 38876123
Background: Artificial intelligence (AI) systems can potentially aid the diagnostic pathway of prostate cancer by alleviating the increasing workload, preventing overdiagnosis, and reducing the dependence on experienced radiologists. We aimed...
6.
Fink C, Buchele C, Baumann L, Liermann J, Hoegen P, Ristau J, et al.
Front Oncol
. 2024 Mar;
14:1308406.
PMID: 38425342
Background: Apart from superior soft tissue contrast, MR-guided stereotactic body radiation therapy (SBRT) offers the chance for daily online plan adaptation. This study reports on the comparison of dose parameters...
7.
Kovacs B, Netzer N, Baumgartner M, Schrader A, Isensee F, Weisser C, et al.
Sci Rep
. 2023 Nov;
13(1):19805.
PMID: 37957250
Prostate cancer (PCa) diagnosis on multi-parametric magnetic resonance images (MRI) requires radiologists with a high level of expertise. Misalignments between the MRI sequences can be caused by patient movement, elastic...
8.
Bauerle T, Dietzel M, Pinker K, Bonekamp D, Zhang K, Schlemmer H, et al.
Rofo
. 2023 Nov;
196(4):354-362.
PMID: 37944934
Background: Imaging biomarkers are quantitative parameters from imaging modalities, which are collected noninvasively, allow conclusions about physiological and pathophysiological processes, and may consist of single (monoparametric) or multiple parameters (bi-...
9.
Ma Y, Moazamian D, Port J, Edjlali M, Pruvo J, Hacein-Bey L, et al.
Quant Imaging Med Surg
. 2023 Oct;
13(10):7304-7337.
PMID: 37869282
This review describes targeted magnetic resonance imaging (tMRI) of small changes in the T and the spatial properties of normal or near normal appearing white or gray matter in disease...
10.
Boschheidgen M, Albers P, Schlemmer H, Hellms S, Bonekamp D, Sauter A, et al.
Eur Urol
. 2023 Oct;
85(2):105-111.
PMID: 37863727
Background: Magnetic resonance imaging (MRI) has been suggested as a tool for guiding biopsy recommendations in prostate cancer (PC) screening. Objective: To determine the performance of multiparametric MRI (mpMRI) in...